ESHIᴹᵀ Mission Statement
ESHIMT is a non-profit organization dedicated to promoting and coordinating the scientific, intellectual and professional activities of individuals working in the following areas: hybrid imaging incorporating two or more imaging modalities, imaging of tissue function, and imaging at cellular and molecular levels.
The mission of the society is to develop clinically relevant imaging probes and technologies and translate them from bench to bedside to help improve patient care. This will be achieved through training, education and research.
ESHIMT is open to anybody working in these areas of imaging including: physicians, scientists, physicists, technologists, radiographers, and others. ESHIMT will foster specific educational and training programmes to evolve and disseminate knowledge about these new areas of imaging in the medical community across Europe and the world.
ESHIMT will support world-leading science and research through scientific conferences and workshops, as well as fostering and supporting international, cross-specialty research projects. ESHIMT will promote hybrid imaging and the validation and implementation of new functional and molecular imaging biomarkers, as well as developing recommendations for their use in clinical and research settings, together with ESR and other national and international bodies. The ultimate goal of the society is to improve hybrid imaging modalities and to foster their translation into routine clinical practice for the benefit of our patients.
President - Thomas Beyer, Vienna/Austria
Thomas Beyer holds a PhD in Physics and is co-developer of combined PET/CT imaging systems. He has a background in research and project management in academia and imaging industry.
Thomas graduated in Physics from the Leipzig University (Germany) and got his PhD in Medical Physics from Surrey University (UK). During his US-based studies he became involved in the development and clinical testing of the first PET/CT prototype (1992-2000) before joining Siemens/CTI PET Systems as an International PET/CT specialist.
In 2002 he became a Research Associate in Nuclear Medicine and Radiology and PET/CT project manager at Essen University Hospital (Germany). In 2006 he became Teaching Professor (Priv.-Doz.) for Experimental Nuclear Medicine at Essen, and joined timaq medical imaging Inc, a Zurich-based Imaging CRO. In 2007 Thomas moved to Philips Medical Systems as International Manager Clinical Science Nuclear Medicine. In 2008 he set up a Zurich-based consulting company for expert advise in cross-modality imaging and applications. He is appointed full professor of Physics of Medical Imaging at the Medical University of Vienna from March 2013.
Thomas is a member of various national and international Medicine organizations, a founding member of the European Association of Nuclear Medicine (EANM) Physics Committee, the European Society of Hybrid Imaging (ESHI) and past Head of the New Technology working group at the Association of Imaging Producers and Equipment Suppliers (AIPES).
Past-President - Katrine Riklund, Umeå/Sweden
Katrine Riklund, graduated at Umeå university in 1988, licensed in radiology in 1994 and in nuclear medicine in 1997. She defended her PhD thesis about radioimmunoscintigraphy and radioimmunotherapy, in 1992, and received a position as senior lecturer in 1993. Since 2002 she is full clinical professor in diagnostic radiology at Umeå University and senior consultant in radiology and nuclear medicine at Umeå University hospital. During 2000-2002 Dr. Riklund was the head of the clinical department of Radiology at Umeå university hospital and is thereafter responsible for the department of nuclear medicine. She was deputy dean of the medical faculty 2008-2011 and the director of the medical school 2011-2016. Since 2016 she is the Pro Vice Chancellor of Umeå university.
Dr. Riklund started her work in science in translational research between immunology and nuclear medicine by developing and evaluating monoclonal antibodies in the diagnosis and treatment of gynecological cancers.Thereafter hybrid imaging took her interest and imaging research in cognition, neuro degeneration and movement disorders was added. Oncologic hybrid imaging of prostate and colorectal cancer is her third area of research.
The linker between the different areas in her research is hybrid imaging, SPECT/CT, PET/CT and PET/MR. The research also includes a focus on dopamine in imaging, both pre- and postsynaptic.
She has many commitments and is the past president of the Swedish Society of Radiology and the Swedish Society of Nuclear Medicine. Among other commitments, she is the chairperson of the Center for Medical Image Science and Visualization at Linköping University, Sweden the Center for Functional Brain Imaging at Umeå University, Sweden as well as the Wallenberg Center for Molecular Medicine at the same university. She is also an ordinary board member of the national facilities SciLifeLab, MedTech4Health and the scientific board of the Swedish Drug Authority. She has served as grant evaluator for the Swedish Radiation Safety Authority, the Swedish Cancer Society and the Swedish Research Council.
Vice-President - Osman Ratib, Geneva/Switzerland
Professor Osman Ratib is dual board certified in cardiology and Nuclear Medicine and carries a PhD in Biomedical Physics in digital imaging. In July 1998 he was appointed as Professor and Vice Chairman of the Department of Radiology at University of California Los Angeles (UCLA).
He was responsible for coordinating the deployment of an enterprise-wide strategy and infrastructure for image management and communication. In July 2005 he returned to Geneva to take the position chair of the Department of Medical Imaging and Information Sciences and head of the Nuclear Medicine division. He pioneered several innovative projects in hybrid molecular imaging PET-CT and SPECT-CT and the first whole-body PET-MRI unit in Europe.
He is founder and president of the OsiriX foundation, a non-profit organization for the promotion of Open-Source software in medicine. Founder and director of the Translational Molecular Imaging Institute in Geneva, created under the joint leadership of to the University of Geneva and Technical university EPFL in Lausanne.
Treasurer - Konstantin Nikolaou, Tuebingen/Germany
Konstantin Nikolaou is Chairman of the Department of Diagnostic and Interventional Radiology in the Department of Radiology at the Eberhard-Karl-University in Tübingen, Germany. Prof. Nikolaou received his MD from the Ludwig-Maximilians-University of Munich in the year 2000, where he also became an Assistant Professor at the Department of Clinical Radiology, University Hospitals Munich, after finalizing his PhD-thesis on the topic of modern cardiovascular computed tomography techniques in 2007.
After working as a section chief of CT/PET-CT and MRI at the same department, he became Vice Chair of the Department of Clinical Radiology at the Ludwig-Maximilian-University in Munich in April 2007.
He also is president of the European Society of Molecular and Functional Imaging in Radiology (ESMOFIR) and treasurer for the European Society of Cardiac Imaging (ESCR), Member of the Research Committee of the European Society of Radiology (ESR) and Honorary Member of the Greek Society of Radiology.
Prof. Konstantin Nikolaou joined the Eberhard-Karl-University Tübingen in April 2014 as Chairman of the Department of Diagnostic and Interventional Radiology. His main fields of interest are multimodality and multi-parametric imaging modalities in oncology as well as non-invasive imaging of cardiovascular diseases.
Member at Large - Fabian Kiessling, Aachen/Germany
Professor Dr. Fabian Kiessling is leading the Institute for Experimental Molecular Imaging at the RWTH-University in Aachen, where he develops novel diagnostic and theranostic concepts, probes and technologies.
Fabian Kiessling studied medicine and graduated at the University of Heidelberg. Until the end of 2002, he worked as resident in the Department of Radiology at the German Cancer Research Center. In 2003 he changed to the Department of Medical Physics in Radiology as leader of a Molecular Imaging group.
In parallel, he did his clinical training and received the board certification as radiologist in 2007. He is author of more than 280 publications and book chapters, received several research awards, among those the „Emil Salzer Price for Cancer Research” and the “Richtzenhain Price” and was appointed to the editorial board of several journals including Radiology, European Radiology, American Journal of Nucelar Medicine and Molecular Imaging, and Nanotheranostics.
Furthermore, he founded the invivoContrast GmbH together with Professor Matthias Bräutigam, which is distributing diagnostic probes for the preclinical market.
Member at Large - Olivier Clément, Paris/France
Pr Olivier Clément, MD, PhD
Professor of Radiology
Hôpital Européen Georges Pompidou, and University Paris Descartes
Service de Radiologie
20 rue LEBLANC,
Chair of Research Committee - Ferdia Gallagher, Cambridge/UK
Dr Ferdia Gallagher studied medicine at both the Universities of Cambridge and Oxford before training as a radiologist at Addenbrooke’s Hospital. He undertook a PhD in Biochemistry in Cambridge as part of a CRUK Clinical Research Training Fellowship; this work focused on a new form of imaging termed hyperpolarized carbon-13 MRI that allows tumour metabolism to be imaged non-invasively in realtime.
He is currently a CRUK Clinician Scientist, University Reader in Molecular Imaging and an Honorary Consultant Radiologist in the Department of Radiology in the University of Cambridge. His main interest is developing new molecular imaging methods to study fundamental biological processes in tumours that can be translated into patient care. These techniques include MRI and PET. Part of this research has involved the translation of hyperpolarized carbon-13 MRI into humans and this has involved creating a bespoke pharmacy facility to assembly the consumables for the clinical hyperpolarizer. In addition, he is currently developing methods to study tumour aggressiveness using diffusional weighted imaging and to probe tissue structure and function using sodium MRI.
He is also interested in new PET tracers, such as labelled sodium fluoride to more accurately stage tumours, and cell labelling methods using 89Zr-PET. The group is also interested in the application of novel trial designs to imaging studies. He sits on the CRUK Clinical Research Committee and the CRUK New Investigators Committee. He is the Chair of the MR of Cancer Study Group within the International Society of Magnetic Resonance in Medicine 2017-18. Dr Gallagher also directs the local Academic Research Training Programme in Radiology.
Chair of Education Committee - Clemens Cyran, Munich/Germany
Term of Office: 2018 – 2020
Clemens C. Cyran, MD
Professor of Radiology
Section Chief PET/CT
Department of Radiology
Laboratory for Experimental Radiology
University Hospitals Munich – Campus Grosshadern
ESHIMT Educational Committee
Chair: Prof. Dr. Clemens Cyran, Munich/Germany
|Dr. Melvin D’Anastasi||Msida/Malta|
|Dr. David Fuster||Barcelona/Spain|
|Prof. Dr. Einat Even-Sapir||Tel Aviv/Israel|
|PD Dr. Freimut Juengling||Basel/Switzerland|
|Prof. Dr. Lutz Freudenberg||Grevenbroich/Germany|
|Prof. Dr. Jiri Ferda||Plzen/Czech Republic|
|Dr. Barbara Fueger||Vienna/Austria|
|Prof. Gary Cook||London/UK|
|Prof. Dr. Christina Pfannenberg||Tuebingen/Germany|
|Prof. Dr. Michael Fuchsjäger||Graz/Austria|
|Dr. Asha Leisser||Vienna/Austria|
|Prof. Dr. Regina Beets-Tan||Amsterdam/Netherlands|
|Prof. Dr. Katrine Riklund||Umeå/ Sweden|
ESHIMT Research Committee
Chair: Dr. Ferdia Gallagher, Cambridge/UK
|Prof. Dr. Bertrand Tavitian||Paris/France|
|Dr. Sergios Gatidis||Tuebingen/Germany|
|Prof. Dr. Esther Troost||Dresden/Germany|
|Dr. James O’Connor||Manchester/UK|
|Dr. Ivo Rausch||Vienna/Austria|
|Dr. Onofrio Catalano||Boston/USA|
ESHIMT representatives at ESR committees
|Subspecialties and Allied Sciences Committee||Katrine Riklund, Umea/Sweden|
|Education Committee||Gerald Antoch, Dusseldorf/Germany|
|Quality, Safety and Standards Committee||Osman Ratib, Geneva/Switzerland|
|Research Committee||Thomas Beyer, Vienna/Austria|
Society controllers (2019-2020)
Christoph Mayer, Vienna/Austria
Georg Varga, Vienna/Austria